Chemed ( (CHE) ) has released its Q1 earnings. Here is a breakdown of the information Chemed presented to its investors.
Chemed Corporation, a diversified company operating in the healthcare and plumbing sectors, reported its financial results for the first quarter of 2025, showcasing growth in its VITAS Healthcare and Roto-Rooter segments.
Chemed’s first-quarter results for 2025 highlighted a 9.8% increase in revenue to $646.9 million, with GAAP diluted earnings per share rising by 14.6% to $4.86. The company’s adjusted diluted EPS also saw an increase of 8.3% to $5.63, indicating robust financial performance.
The VITAS Healthcare segment experienced a significant boost, with net patient revenue climbing 15.1% to $407.4 million. This growth was driven by a 13.1% rise in the average daily census and a 7.3% increase in admissions. The acquisition of Covenant Health’s hospice assets contributed approximately $11.5 million to $12.5 million in revenue. Meanwhile, Roto-Rooter saw a modest revenue increase of 1.8% to $239.5 million, although its net income and adjusted EBITDA experienced slight declines.
Despite the challenges in the Roto-Rooter segment, Chemed maintains a strong financial position with $173.9 million in cash and no debt. The company also repurchased 50,000 shares of its stock, reflecting confidence in its future prospects.
Looking ahead, Chemed’s management remains optimistic about the company’s growth trajectory, with plans to update its 2025 earnings guidance in the upcoming June earnings release. This forward-looking approach suggests a continued focus on strategic growth and shareholder value.